Further, TNFRSF10B expression is lower in higher grade prostate tumours and a recent study of PARP inhibitors in prostate cancer cell lines suggested that TNFRSF10B may provide a mechanism by which the cancer drug olaparib induces apoptosis.60 Here, TNFRSF10B is linked to prostate carcinoma.